FDA approves AstraZeneca's lung cancer drug as first-line treatment
July 13, 2015 at 13:54 PM EDT
July 13 (Reuters) - The U.S. Food and Drug Administration has approved AstraZeneca Plc's drug, Iressa, as a first-line treatment for a common form of lung cancer.
